We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$909M
AUM Growth
+$60.4M
Cap. Flow
-$18.4M
Cap. Flow %
-2.03%
Top 10 Hldgs %
34.5%
Holding
785
New
115
Increased
116
Reduced
118
Closed
114

Top Buys

Rank Stock Value
1
CBRE icon
CBRE Group
CBRE
+$2.32M
2
SLB icon
SLB Ltd
SLB
+$1.9M
3
WM icon
Waste Management
WM
+$1.66M
4
DLR icon
Digital Realty Trust
DLR
+$1.48M
5
ES icon
Eversource Energy
ES
+$1.39M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.37M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.64M
3
PSX icon
Phillips 66
PSX
+$1.94M
4
DHR icon
Danaher
DHR
+$1.8M
5
META icon
Meta Platforms (Facebook)
META
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 18.99%
2 Healthcare 11.59%
3 Financials 10%
4 Consumer Discretionary 8.79%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLIC icon
551
Kulicke & Soffa
KLIC
$4.78B
$221K 0.02%
9,850
LZB icon
552
La-Z-Boy
LZB
$1.69B
$220K 0.02%
+6,970
New +$212K
NX icon
553
Quanex
NX
$1.01B
$220K 0.02%
11,930
VIVO
554
DELISTED
Meridian Bioscience Inc
VIVO
$220K 0.02%
+12,960
New +$252K
IBTX
555
DELISTED
Independent Bank Group, Inc.
IBTX
$220K 0.02%
+4,980
New +$220K
ENTA icon
556
Enanta Pharmaceuticals
ENTA
$400M
$219K 0.02%
+4,780
New +$232K
SUPN icon
557
Supernus Pharmaceuticals
SUPN
$2.77B
$216K 0.02%
10,380
CHRS icon
558
Coherus Oncology
CHRS
$196M
$214K 0.02%
+11,690
New +$217K
ADEA icon
559
Adeia
ADEA
$3.11B
$213K 0.02%
+70,047
New +$259K
SAFE
560
DELISTED
Safehold Inc.
SAFE
$213K 0.02%
+3,430
New +$186K
DRH icon
561
Diamondrock Hospitality Co
DRH
$2.56B
$212K 0.02%
41,780
LNN icon
562
Lindsay Corp
LNN
$1.18B
$212K 0.02%
2,190
NWBI icon
563
Northwest Bancshares
NWBI
$2.28B
$212K 0.02%
23,090
BOOM icon
564
DMC Global
BOOM
$157M
$209K 0.02%
+6,340
New +$200K
MSTR icon
565
Strategy Inc
MSTR
$38.4B
$209K 0.02%
+13,900
New +$188K
SNEX icon
566
StoneX
SNEX
$7.94B
$209K 0.02%
20,706
XHR
567
Xenia Hotels & Resorts
XHR
$1.79B
$209K 0.02%
23,860
MRTN icon
568
Marten Transport
MRTN
$1.22B
$208K 0.02%
12,750
B
569
DELISTED
Barnes Group Inc.
B
$208K 0.02%
5,820
-3,300
-36% -$125K
RAVN
570
DELISTED
Raven Industries Inc
RAVN
$208K 0.02%
9,680
PRDO icon
571
Perdoceo Education
PRDO
$2.12B
$205K 0.02%
16,740
TSE
572
DELISTED
Trinseo
TSE
$205K 0.02%
+7,990
New +$199K
UCB
573
United Community Banks
UCB
$4.28B
$204K 0.02%
12,060
FMBI
574
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$204K 0.02%
18,900
CTB
575
DELISTED
Cooper Tire & Rubber Co.
CTB
$204K 0.02%
+6,440
New +$210K

Similar funds

Everence Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Everence Capital Management held 785 positions worth $909M, up 7.1% from $849M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Everence Capital Management's Q3 2020 filing shows 115 new, 116 increased, 118 reduced and 114 closed positions. Its largest new stake was Global Payments: 5,650 shares worth $1M. The largest sale was Apple, an estimated $3.37M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Everence Capital Management's largest Q3 2020 buy was Global Payments: 5,650 shares worth $1M.
  • Everence Capital Management added most to CBRE Group in Q3 2020, an estimated $2.32M increase.
  • Everence Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $3.37M.
  • Everence Capital Management fully exited Phillips 66 in Q3 2020, selling an estimated $1.94M.
  • Everence Capital Management's ten largest holdings make up 34% of its $909M portfolio in Q3 2020.
  • Everence Capital Management opened 115 new positions and closed 114 in Q3 2020.
  • Everence Capital Management's portfolio value rose 7.1% quarter-over-quarter to $909M.

Based on Everence Capital Management's 13F filing for Q3 2020, filed 20 Oct 2020.